The Teva Pharmaceutical Industries Limited (NYSE:TEVA) Yearly Results Are Out And Analysts Have Published New Forecasts
Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance at 8 a.m. ET on February 10, 2021 | Business Wire
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Reports First Quarter 2021 Financial Results | Business Wire
Teva Pharmaceutical Industries Ltd. - Yesterday we shared Teva's Q1 2020 financial results. View the highlights of our contributions to #COVID19 efforts worldwide, focusing on employee safety and ensuring that quality medicines
Is TEVA a Pain Before the Gain? – PGM Capital
Teva Pharmaceutical Industries Ltd.'s Q3 Helped by Actavis Generics Deal -- but Not Quite Enough | Fox Business
Teva shares rise in Tel Aviv as migraine results buoy investors | The Times of Israel
Teva's Trial Results finds drug could slow Huntington's disease - Jewish Business News
Teva, MedinCell announce positive results for registration trial of TV-46000/mdc-IRM for patients with Schizophrenia - Pharmaceutical Business review
Teva cuts forecast for 2017 amid competition to flagship Copaxone drug | The Times of Israel
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva Reports Second Quarter 2021 Financial Results | Business Wire